{"disease":{"id":"chronic-myeloid-leukemia-in-blast-crisis","name":"chronic myeloid leukemia in blast crisis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03869502","title":"European CML Blast Crisis Register","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"University of Jena","has_results":false},{"nct_id":"NCT03595917","title":"ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Marlise Luskin, MD","has_results":false},{"nct_id":"NCT05376852","title":"Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}